Form 4 for PG Procter & Gamble
Accepted 2025-08-21 00:00:00 ET · period of report 2025-08-19 · accession 0000080424-25-000138 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-21 | 2025-08-19 | PG | Davis Jennifer L. | CEO - Health Care | S - Sale | $157.27 | -8,596 | 65.0K | -12% | -$1.35M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-19 | S | D | 8,596 | $157.27 | 64,990.93 | D | — | — | (F1) Shares sold to cover taxes on Stock Award. |